Follow Us
https://www.thebody.com/category/sustiva-efavirenz-stocrin/tag/news

The Latest

Among Anti-HIV Drugs, Only Sustiva Has Possible Impact on Contraceptives Img

Among Anti-HIV Drugs, Only Sustiva Has Possible Impact on Contraceptives

Most HIV drugs have little or no impact on the effectiveness of hormonal contraceptives, with the possible exception of Sustiva (efavirenz).

Sustiva and Suicide: Don't Be Scared, but Be Aware Img

Sustiva and Suicide: Don't Be Scared, but Be Aware

Mental health really matters in HIV. We got a hugely important reminder of that this month in the form of new research regarding suicide and Sustiva (also known as Stocrin or efavirenz; part of the fixed-dose combination pill Atripla). The research ...

Case Report Shows Gingko May Interact With Sustiva

In a Dutch case study of one individual living with HIV, gingko biloba appeared to interact with the HIV drug Sustiva (efavirenz), causing it to fail in this person. The data were reported in AIDS in June 2009. The 47-year-old man had been on stable ...

Life After Sustiva: Depression, Anxiety Side Effects

I am so grateful to POZ magazine for a recent article published by its founder, Sean Strub, in the February/March 2004 issue. In his article, Sean outlines his three-month experience with Sustiva (efavirenz), which led him into a spiraling depressi...

IATEC Presents the 2NN Study Results

The non-nucleoside reverse transcriptase inhibitors (NNRTIs), Sustiva (efavirenz) and Viramune (nevaripine), are now very commonly used as part of first-line HAART regimens. Previously, there was no data directly comparing the two NNRTIs nor the comb...

Merck to Cut Cost of AIDS Drug in Poorest Nations

In an effort to stay one step ahead of AIDS activists and generic competitors, Merck & Co. said it will cut the price of its new once-daily pill Stocrin to less than $1 a day in the poorest and hardest-hit countries -- a reduction of more than 30 per...

Sustiva (Efavirenz) in New Formulation

The Food and Drug Administration approved on February 1, 2002, a new formulation of Sustiva (efavirenz). Sustiva is a once-daily non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination treatment for HIV. The new formulation will pr...

Evaluation of Novel Combination of Abacavir, Lamivudine and Efavirenz

Use of efavirenz in a low-income population (Poster, WePeB4138) Authored by D. Parrish, J. Godbey Evaluation of novel combination of abacavir (ABC), lamivudine (3TC) and efavirenz (EFV) (Poster, WePeB4139) Authored by J. Godbey, D. Parris...

Efavirenz (Sustiva®): Oral Liquid Expanded Access Program for Children and Adolescents Ages 3-16

Efavirenz is an approved antiretroviral currently available in the U.S. and other countries in capsule form -- and recommended for pediatric use in the latest Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (January 2000). ...

Efficacy of Efavirenz (Sustiva) Concerning Regimens in Patients With Baseline Plasma HIV-1 RNA Viral Load Exceeding 100,000 copies/mL

Sustiva is a once-daily non-nucleoside reverse transcriptase inhibitor (NNRTI) which has demonstrated efficacy when used combination with either a protease inhibitor, NRTI or both in ARV naïve NRTI extreme patients. The antiretroviral activity of NNR...